61 related articles for article (PubMed ID: 16685153)
1. [Lung carcinoma].
Sutani A; Kobayashi K
Gan To Kagaku Ryoho; 2006 May; 33(5):590-4. PubMed ID: 16685153
[TBL] [Abstract][Full Text] [Related]
2. [Outpatient chemotherapy for lung cancer].
Yoneda S
Gan To Kagaku Ryoho; 2007 Apr; 34(4):533-7. PubMed ID: 17431337
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced non-small cell lung cancer: past, present, and future.
Ramanathan RK; Belani CP
Semin Oncol; 1997 Aug; 24(4):440-54. PubMed ID: 9280224
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
Belani C;
Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
[TBL] [Abstract][Full Text] [Related]
6. Re: Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Malayeri R
J Natl Cancer Inst; 2002 Aug; 94(15):1172; author reply 1172. PubMed ID: 12165643
[No Abstract] [Full Text] [Related]
7. [Treatment of unresectable non-small-cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 2000 Mar; 27(3):356-61. PubMed ID: 10740628
[TBL] [Abstract][Full Text] [Related]
8. [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].
Chohnabayashi N; Uchiyama N; Nishimura N; Nasu H
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1395-8. PubMed ID: 15446564
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel/platinum combination provides quality-of-life advantage over vinorelbine/cisplatin in advanced lung cancer.
Oncology (Williston Park); 2002 Aug; 16(8):1052. PubMed ID: 12201644
[No Abstract] [Full Text] [Related]
10. Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer.
Krug LM; Miller VA
Semin Oncol; 1999 Oct; 26(5 Suppl 16):24-6; discussion 41-2. PubMed ID: 10585005
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
12. A brief historical review of the development of chemotherapy for the treatment of advanced non-small cell lung cancer: why we should look beyond platinum.
Bengtson EM; Rigas JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):1-6. PubMed ID: 10585002
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in lung cancer].
Seto T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1202-6. PubMed ID: 17847581
[No Abstract] [Full Text] [Related]
14. Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.
Pectasides D; Fountzilas G; Rigopoulos A; Bountouroglou NG; Koutras A; Glotsos J; Onyenadum A; Makatsoris T; Kalofonos HP
Anticancer Res; 2002; 22(6B):3501-6. PubMed ID: 12552946
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
[TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
17. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
Ou W; Sun HB; Ye X; Zhang BB; Yang H; Fang Q; Li P; Wang SY
J Thorac Oncol; 2010 Jul; 5(7):1033-41. PubMed ID: 20502361
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients.
Schmittel A; Siehl JM; Schulze M; Schulze K; Thiel E; Keilholz U
Anticancer Res; 2005; 25(2B):1333-6. PubMed ID: 15865087
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.
Moinpour CM; Lyons B; Grevstad PK; Lovato LC; Crowley J; Czaplicki K; Buckner ZM; Ganz PA; Kelly K; Gandara DR
Qual Life Res; 2002 Mar; 11(2):115-26. PubMed ID: 12018735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
